Fail safe: Changing a broken approach to patient medication safety

Jacques Turgeon, BPharm, PhD, TRHC Chief Scientific Officer and CEO of Precision Pharmacotherapy Research and Development Institute, co-authored an article for Drug Store News that outlines how the traditional approach to medication safety lacks precision, personalization, and proactive analysis. Importantly, the traditional approach uses multiple one-to-one drug analyses, ignoring simultaneous, multi-drug interactions. As a result, the approach leaves patients at risk for avoidable adverse drug events.